Scientists in China announced on 25th of November with great concern that there is a new Covid-like virus out of the five viruses of concern discovered among bats across Yunnan province. It was reported that this Covid-like virus BtSY2 has high potential of infecting humans as it comprises a receptor binding domain which is a vital part of the spike protein used to lay hold of human cells and subsequently utilize human ACE2 receptor for cell entry similar to the SARS-CoV-2. In a bid , it is expedient for and the world to keep an eye on this Covid-like virus capable of spreading from bats to humans because most pandemic outbreaks in recent decades have arisen in such a manner. Strict actions should be implemented in impeding transmission to humans which is paramount to battling viral diseases as learnt from history that viral outbreaks are very impossible to eradicate after global outbreak. Health officials and the World Health Organization should invest urgently in more research to further study this new Covid-like virus with an approach to prepare for a possible viral outbreak, and develop treatment options and possible vaccines to outsmart the danger posed to human health.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040890 | PMC |
| http://dx.doi.org/10.1016/j.jtumed.2023.03.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A statistical modelling approach for determining the cause of reported respiratory syndromes from internet-based participatory surveillance when influenza virus and SARS-CoV-2 are co-circulating.
PLOS Digit Health
December 2024
Centre for Infectious Disease Control, Netherlands National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Article Synopsis
- Symptom-only definitions for COVID-like illnesses fail to differentiate between COVID-19, influenza, and other respiratory infections due to overlapping symptoms.
- A new statistical method was developed to attribute cases of acute respiratory infections (ARI) to either influenza or SARS-CoV-2 without relying solely on symptom definitions, using data from the Netherlands in early 2022.
- The model estimated that during the analysis period, 35.4% of ARI cases were attributable to influenza and 27.0% to SARS-CoV-2, highlighting its potential for use in other countries with similar surveillance systems.
The impact of SARS-CoV-2 on emergency health care demand: inverse relationship between COVID-like illnesses and ED accesses in Genoa, Italy.
J Prev Med Hyg
June 2024
Department of Health Sciences (DISSAL), University of Genoa.
Introduction: SARS-CoV-2 has changed the demand for in-person health care. The aim of this study was to retrospectively analyzed data on access to San Martino Hospital Emergency Department (ED), Genoa, Italy, during the COVID-19 pandemic.
Methods: Descriptive statistics for 180,117 records of patients accessing the ED between 2019 and 2021 were reported.
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
PLoS Med
July 2024
Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Background: Rapid diagnostic tests (RDTs) for coronavirus disease (COVID) are used in low- and middle-income countries (LMICs) to inform treatment decisions. However, to date, it is unclear when this use is cost-effective. Existing analyses are limited to a narrow set of countries and uses.
View Article and Find Full Text PDFImpact of the Early COVID-19 Pandemic on Emergency Department Visits of Adult Cancer Patients With Fever or Respiratory Symptoms: A Korean Nationwide Population-Based Study, 2016-2020.
J Korean Med Sci
June 2024
Public Health Research Institute, National Medical Center, Seoul, Korea.
Background: We performed a nationwide analysis to evaluate the impact of the early coronavirus disease 2019 (COVID-19) pandemic on emergency department (ED) visits by adult cancer patients having COVID-like symptoms.
Methods: We analyzed the National Emergency Department Information System (NEDIS) data on ED visits by adult cancer patients who presented with chief complaints of fever or respiratory symptoms (FRS) indicative of COVID-19, from 2016 to 2020. An interrupted time series analysis with a quasi-Poisson regression model was performed, adjusting for seasonality and time, to evaluate whether underlying trends for monthly ED visits and the in-hospital mortality rate (%) per month changed with the pandemic among these patients.
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh.
Sci Rep
May 2024
Immunobiology, Nutrition and Toxicology Laboratory, Nutrition Research Division, International Center for Diarrhoeal Disease Research, Bangladesh (icddr, b), Dhaka, 1212, Bangladesh.
COVID-19 vaccines have been effective in preventing severe illness, hospitalization and death, however, the effectiveness diminishes with time. Here, we evaluated the longevity of antibodies generated by COIVD-19 vaccines and the risk of (re)infection in Bangladeshi population. Adults receiving two doses of AstraZeneca, Pfizer, Moderna or Sinopharm vaccines were enrolled at 2-4 weeks after second dosing and followed-up at 4-monthly interval for 1 year.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!